• 3
  • 评论
  • 收藏

NIO Could Fail In FQ2 2022 - But The Patient May Be Rewarded By H2 2022

Seekingalpha2022-06-15

Investment ThesisIt is evident that NIO Inc. (NYSE:NIO) will face a challenging YoY comparison from FQ2'22 onwards, given the massive impact of China's ongoing Zero Covid Policy in Shanghai. The ...

网页链接

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

举报

评论

  • eirsh
    ·2022-06-15
    Yuji
    回复
    举报
    收起
    • eirsh
      huji
      2022-07-04
      回复
      举报
 
 
 
 

热议股票

 
 
 
 
 

7x24